Santa Cruz Biotechnology features a diverse variety of ZPI Antibodies for advanced research in cellular biology. ZPI Antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZPI, or Z-DNA binding protein 1, plays a crucial role in the regulation of gene expression and is involved in the cellular response to viral infections. By binding to Z-DNA, ZPI influences the immune response and modulates the activity of various transcription factors, making it a key component in the study of immune signaling pathways. Understanding ZPI function is essential for elucidating mechanisms of disease and developing therapeutic strategies. Research into ZPI continues to reveal new insights about its role in cellular processes and potential therapeutic applications. Investigating ZPI expression patterns helps scientists better understand immune system regulation and viral defense mechanisms. ZPI research has significant implications for developing new treatments for immune-related disorders and viral infections. Santa Cruz Biotechnology monoclonal antibodies for ZPI support researchers worldwide in advancing scientific understanding of immune system regulation and disease mechanisms.